Abstract
Currently atherosclerosis is the main cause of infarct in the world. The MMP-2 seems one of the proteases that plays a major role in this disease because it has been related to rupture of atherosclerotic plaques. Several studies demonstrated that inhibitors that act on MMP-2 activity are beneficial for cardiovascular diseases. However, to date, few studies have demonstrated the direct act…